David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251

1 May 2026 · 24 min
Episode

1 May 2026 · 24 min

0:00

David Sinclair warns that GLP-1 drugs can cause a rare blindness called NION and suggests micro-dosing under doctor supervision. His lab uses AI systems like Cadence to screen trillions of molecules and test whether his OSK/ER100 platform can reverse age-related blindness and ALS. He argues genetics account for only half of lifespan, the rest depends on eating stressed plants, movement, sleep, and deliberate stress like sauna.

Chapters

More from Dave

46:20
Podcast

Ep. 313 – Touching the Sun

3w ago
51:14
Podcast

Confessions of a Democratic Operative

3w ago
37:49
Podcast

Episode 504: Exploring the Clinical Side of Medical Cannabis with Dr. Hemant K. Bid

3w ago
2:07:20
Podcast

Robinhood's Vlad Tenev on Tokenizing Everything, OpenAI's 6 Misalignment Reports, Figure's Robot Makes Beds | EP #292

3w ago
50:02
Podcast

Big mysteries explained through your senses

3w ago
2:22:54
Podcast

Frontier Labs Want to Slow Down, OpenAI Delays Its 2026 IPO, Anthropic Flags 5 Bioweapon Cases | EP #291

3w ago
3:43:50
Podcast

#502 – Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung

4w ago
1:44:11
Podcast

The Psychology of Motivation | Dr. Masud Husain

4w ago
11:41
Podcast

A startup claims it’s found a drug to make your blood young

4w ago
19:23
Podcast

90% of AI prototypes never reach production (w/ Temporal's Samar Abbas) | AI Basics

4w ago
50:21
Podcast

Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030

1mo ago
See all content